The Pershing Square Sohn Prize for Young Investigators in Cancer Research is an annual award to fund the most promising young scientists in New York City’s medical institutions and universities. It serves as a catalyst for collaboration among scientists, academics, nonprofits, business investors, and the biotech and pharmaceutical industries. The program seeks to guide philanthropic funds to feed critical scientific discoveries, attracting like-minded philanthropic investors to the cause of fighting cancer and creating a pipeline for early-stage biomedical investments.
The program associated with the Prize will facilitate collaboration with other departments within and across institutions. It will require young researchers to partner with a mentor in the pharmaceutical industry to facilitate drug development in the quest for cures. The program will culminate with a retreat for the Prize recipients, where academic and pharmaceutical scientists, investors and philanthropists will connect and share ideas. The Pershing Square Sohn Prize winners will present their most innovative and promising work to a business audience at the annual Sohn Investment Conference.